N@N

Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $25 on, Jun 26th, 2023

Joseph Stringer of Needham, Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $25 on, Jun 26th, 2023.

Joseph has made no other calls on STOK in the last 4 months.

There are 6 other peers that have a rating on STOK. Out of the 6 peers that are also analyzing STOK, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Greg Harrison of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $12 on, Monday, May 1st, 2023

These are the ratings of the 5 analyists that currently disagree with Joseph

---

• Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Thursday, June 8th, 2023
• Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $25 on, Tuesday, May 23rd, 2023
• Judah Frommer of "Credit Suisse" Reiterated at Buy and Held Target at $28 on, Friday, May 5th, 2023
• Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $24 on, Wednesday, April 26th, 2023
• Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023

Contributing Sources

---